Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 4
1997 3
1998 3
1999 5
2000 4
2001 7
2002 9
2003 6
2004 10
2005 10
2006 7
2007 8
2008 12
2009 5
2010 7
2011 8
2012 14
2013 9
2014 14
2015 11
2016 12
2017 8
2018 7
2019 5
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

182 results
Results by year
Filters applied: . Clear all
Page 1
The expression of galectin-3 in breast cancer and its association with chemoresistance: a systematic review of the literature.
Boutas I, Potiris A, Brenner W, Lebrecht A, Hasenburg A, Kalantaridou S, Schmidt M. Boutas I, et al. Arch Gynecol Obstet. 2019 Nov;300(5):1113-1120. doi: 10.1007/s00404-019-05292-9. Epub 2019 Sep 9. Arch Gynecol Obstet. 2019. PMID: 31502061
In this systematic review, our primary goal is to identify the effect of galectin-3 expression in association with drug resistance and apoptosis inhibition in breast cancer. MATERIALS AND METHODS: Scopus and PubMed databases were searched on 26 Novembe …
In this systematic review, our primary goal is to identify the effect of galectin-3 expression in association with drug resist …
The clinical importance of serum galectin-3 levels in breast cancer patients with and without metastasis.
Topcu TO, Kavgaci H, Gunaldi M, Kocoglu H, Akyol M, Mentese A, Yaman SO, Orem A, Ozdemir F, Aydin F. Topcu TO, et al. J Cancer Res Ther. 2018 Sep;14(Supplement):S583-S586. doi: 10.4103/0973-1482.176425. J Cancer Res Ther. 2018. PMID: 30249872 Free article.
OBJECTIVE: Studies have investigated expression status of galectin-3 (Gal-3), but very little is known about the importance of circulating Gal-3 in patients with breast cancer (BC). ...Levels of Gal-3 were investigated in BC patien …
OBJECTIVE: Studies have investigated expression status of galectin-3 (Gal-3), but very little is known about the import …
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.
Sciacchitano S, Lavra L, Morgante A, Ulivieri A, Magi F, De Francesco GP, Bellotti C, Salehi LB, Ricci A. Sciacchitano S, et al. Int J Mol Sci. 2018 Jan 26;19(2):379. doi: 10.3390/ijms19020379. Int J Mol Sci. 2018. PMID: 29373564 Free PMC article. Review.
Galectin-3 (Gal-3) regulates basic cellular functions such as cell-cell and cell-matrix interactions, growth, proliferation, differentiation, and inflammation. It is not surprising, therefore, that this protein is involved in the pathogenesis of many relevant …
Galectin-3 (Gal-3) regulates basic cellular functions such as cell-cell and cell-matrix interactions, growth, prolifera …
Galectin-3 Regulates the Expression of Tumor Glycosaminoglycans and Increases the Metastatic Potential of Breast Cancer.
Pereira JX, Dos Santos SN, Pereira TC, Cabanel M, Chammas R, de Oliveira FL, Bernardes ES, El-Cheikh MC. Pereira JX, et al. J Oncol. 2019 Dec 17;2019:9827147. doi: 10.1155/2019/9827147. eCollection 2019. J Oncol. 2019. PMID: 31949431 Free PMC article.
Galectin-3 (Gal-3) is a multifunctional β-galactoside-binding lectin that once synthesized is expressed in the nucleus, cytoplasm, cell surface, and extracellular environment. ...Here, we showed that Gal-3 knockdown increased the migration ability of 4 …
Galectin-3 (Gal-3) is a multifunctional β-galactoside-binding lectin that once synthesized is expressed in the nucleus, …
Functional impact of Galectin-3 and TRAIL expression in breast cancer cells.
Liu XH, Deng CX, Hu PC, Wang Y, Dong YH. Liu XH, et al. Eur Rev Med Pharmacol Sci. 2017 Aug;21(16):3626-3633. Eur Rev Med Pharmacol Sci. 2017. PMID: 28925481 Free article.
OBJECTIVE: To examine the expression of Galectin-3 and TRAIL in breast cancer tissue and their effects on the proliferation and apoptosis of breast cancer cells. ...The correlation between the expressions of Galectin-3 and T …
OBJECTIVE: To examine the expression of Galectin-3 and TRAIL in breast cancer tissue and their effects on the pr …
Circulating neuregulin-1 and galectin-3 can be prognostic markers in breast cancer.
De Iuliis F, Salerno G, Taglieri L, Lanza R, Cardelli P, Scarpa S. De Iuliis F, et al. Int J Biol Markers. 2017 Jul 24;32(3):e333-e336. doi: 10.5301/ijbm.5000262. Int J Biol Markers. 2017. PMID: 28430337 Free article.
Neuregulin-1 (NRG1) and galectin-3 (Gal-3) are proteins that are involved in breast cancer development and patient survival; therefore, we studied whether the serum concentration of these 2 proteins can be correlated to breast cancer …
Neuregulin-1 (NRG1) and galectin-3 (Gal-3) are proteins that are involved in breast cancer development an …
Extracellular and intracellular small-molecule galectin-3 inhibitors.
Stegmayr J, Zetterberg F, Carlsson MC, Huang X, Sharma G, Kahl-Knutson B, Schambye H, Nilsson UJ, Oredsson S, Leffler H. Stegmayr J, et al. Sci Rep. 2019 Feb 18;9(1):2186. doi: 10.1038/s41598-019-38497-8. Sci Rep. 2019. PMID: 30778105 Free PMC article.
Galectin-3 is a carbohydrate binding protein which has important roles in cancer and immunity. Potent galectin-3 inhibitors have been synthesized, for experimental purposes and potential clinical use. ...All inhibitors were equally able to block …
Galectin-3 is a carbohydrate binding protein which has important roles in cancer and immunity. Potent galectin- …
Galectin-3 as a marker and potential therapeutic target in breast cancer.
Zhang H, Luo M, Liang X, Wang D, Gu X, Duan C, Gu H, Chen G, Zhao X, Zhao Z, Liu C. Zhang H, et al. PLoS One. 2014 Sep 25;9(9):e103482. doi: 10.1371/journal.pone.0103482. eCollection 2014. PLoS One. 2014. PMID: 25254965 Free PMC article.
However, the clinical and prognostic implications of galectin-3 expression in breast cancer remain unclear. We examined mastectomy specimens from 1086 breast cancer cases and matching, adjacent non-cancerous tissues using immunohistochemi …
However, the clinical and prognostic implications of galectin-3 expression in breast cancer remain unclear. We e …
Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis.
Nakajima K, Kho DH, Yanagawa T, Harazono Y, Hogan V, Chen W, Ali-Fehmi R, Mehra R, Raz A. Nakajima K, et al. Cancer Res. 2016 Mar 15;76(6):1391-402. doi: 10.1158/0008-5472.CAN-15-1793. Epub 2016 Feb 2. Cancer Res. 2016. PMID: 26837763 Free PMC article.
Galectin-3 (Gal-3) has been implicated as a secreted factor that alters the bone microenvironment. Proteolytic cleavage of Gal-3 may also contribute to malignant cellular behaviors, but has not been addressed in cancer metastasis. ...During oste …
Galectin-3 (Gal-3) has been implicated as a secreted factor that alters the bone microenvironment. Proteolytic cleavage …
Galectin-3 Binding Protein and Galectin-1 Interaction in Breast Cancer Cell Aggregation and Metastasis.
Lin TW, Chang HT, Chen CH, Chen CH, Lin SW, Hsu TL, Wong CH. Lin TW, et al. J Am Chem Soc. 2015 Aug 5;137(30):9685-93. doi: 10.1021/jacs.5b04744. Epub 2015 Jul 22. J Am Chem Soc. 2015. PMID: 26168351
Gal-3BP can induce galectin-mediated tumor cell aggregation to increase the survival of cancer cells in the bloodstream during the metastatic process. ...This study elucidates the specificity of Gal-3BP interacting with galectin-1 and the role of Gal-3BP in …
Gal-3BP can induce galectin-mediated tumor cell aggregation to increase the survival of cancer cells in the bloodstream during …
182 results
Jump to page
Feedback